A DP receptor antagonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

BW A868C

Item No. 12060

Technical Information
Formal Name
3-[(2-cyclohexyl-2-hydroxyethyl)amino]-2,5-dioxo-1-(phenylmethyl)-4-imidazolidineheptanoic acid
CAS Number
118675-50-6
Molecular Formula
C25H37N3O5
Formula Weight
Purity
≥98%
Formulation
A 10 mg/ml solution in ethanol
DMF: 30 mg/mlDMSO: 20 mg/mlEthanol: 50 mg/mlPBS (pH 7.2): 250 µg/ml
SMILES
O=C1C(CCCCCCC(O)=O)N(NCC(O)C2CCCCC2)C(N1CC3=CC=CC=C3)=O
InChi Code
InChI=1S/C25H37N3O5/c29-22(20-13-7-4-8-14-20)17-26-28-21(15-9-1-2-10-16-23(30)31)24(32)27(25(28)33)18-19-11-5-3-6-12-19/h3,5-6,11-12,20-22,26,29H,1-2,4,7-10,13-18H2,(H,30,31)
InChi Key
YZJVWSKJHGEIBL-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    BW A868C is a hydantoin compound that is structurally related to the DP receptor agonist BW 245C.1,2 BW A868C antagonizes the prostaglandin D2 and BW 245C-induced activation of human platelet adenylate cyclase. It reverses the anti-aggregatory effects of DP receptor agonists in a dose-dependent manner. Likewise, BW A868C antagonizes the accumulation of cAMP in rabbit non-pigmented ciliary epithelial cells.3 It has virtually no effect on human TP, IP, EP1, EP2, and FP receptors. The Ki for BW A868C is approximately 1.7 nM.4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Caldwell, A.G., Harris, C.J., Stepney, R., et alHydantoin prostaglandin analogues, potent and selective inhibitors of platelet aggregation. J. Chem. Soc. Chem. Comm. 561-562 (1979).

    2. Trist, D.G., Collins, B.A., Wood, J., et alThe antagonism by BW A868C of PGD2 and BW245C activation of human platelet adenylate cyclase. Br. J. Pharmacol. 96(2), 301-306 (1989).

    3. Bhattacherjee, P., Jacobs, N., Coca-Prados, M., et alIdentification of prostanoid receptors in rabbit non-pigmented ciliary epithelial cells. Exp. Eye Res. 62(5), 491-498 (1996).

    4. Giles, H., Leff, P., Bolofo, M.L., et alThe classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist. Br. J. Pharmacol. 96(2), 291-300 (1989).